Cytek Biosciences, Inc., a leading innovator in the field of flow cytometry, is headquartered in the United States, with significant operations across North America, Europe, and Asia. Founded in 2014, the company has rapidly established itself as a key player in the life sciences industry, focusing on advanced cell analysis technologies. Cytek is renowned for its unique spectral flow cytometry systems, which offer unparalleled sensitivity and resolution, enabling researchers to gain deeper insights into cellular functions. Their flagship products, including the Aurora and Northern Lights systems, are distinguished by their ability to analyse complex samples with high-dimensional data. With a commitment to advancing scientific research, Cytek Biosciences has achieved notable milestones, including rapid growth in market share and recognition for its innovative solutions, solidifying its position as a trusted partner in the global scientific community.
How does Cytek Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cytek Biosciences, Inc.'s score of 25 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cytek Biosciences, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. As a result, Cytek Biosciences, Inc. has not established any significant climate commitments or initiatives to report at this time. The company does not inherit emissions data from a parent organisation, and all information is derived directly from Cytek Biosciences, Inc. In the context of the industry, it is essential for companies to adopt robust climate strategies and set measurable targets to mitigate their environmental impact. However, without specific data or commitments, it is challenging to assess Cytek Biosciences, Inc.'s position in this regard.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cytek Biosciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.